• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    U.S. FDA Approves CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37%

    PRNEWSWIRE

    Horizon Therapeutics Announces Availability of PROCYSBI® (Cysteamine Bitartrate)

    BIOSPACE

    Enforcement Report - Week of April 25, 2018

    FDA

    Canadian Government is Investigating Price of Genetic Disease Treatment

    RAPS

    Canada probes Horizon Pharma over efforts to boost sales of a rare disease drug

    STAT NEWS

    Enforcement Report - Week of March 7, 2018

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.